Table S6 from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues

Autor: Mark Drost, Tjalling Bosse, Niels de Wind, Vincent T.H.B.M. Smit, David N. Church, Ian P.M. Tomlinson, Carien L. Creutzberg, Remi A. Nout, Elisabeth M. Osse, Emily Rayner, Inge C. Van Gool
Rok vydání: 2023
Popis: Sensitivity to nucleoside analogs gemcitabine, cladribine and clofarabine conferred by Pole proofreading domain mutations in a cell-based model
Databáze: OpenAIRE